黑料网

Journal of Clinical & Experimental Neuroimmunology
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Clin Exp Neuroimmunol 8: 174,

An update on recent amyotrophic lateral sclerosis developments Prognostic categories for amyotrophic lateral sclerosis

Adelino Canario*
Institute of Clinical Neurobiology, Innsbruck Medical University, Austria
*Corresponding Author : Adelino Canario, Institute of Clinical Neurobiology, Innsbruck Medical University, Austria, Tel: 1187421953230, Email: CanarioA@gmail.com

Received Date: Mar 02, 2023 / Published Date: Mar 30, 2023

Abstract

The name of the motor neuron disease with the highest prevalence is amyotrophic lateral sclerosis (ALS). It usually has adult-onset degeneration of the upper and lower motor neurons and results in mortality a few years after beginning. Several of the known mutant genes present in familial cases of the disease have also been detected in sporadic forms of the disease. A percentage of ALS patients have an inherited form of the disease. The many ALS-linked gene products, which affect the disease's course and diminish voluntary motor capacity, are not completely understood. This review explores the important developments in our understanding of the disease's underlying underpinnings, which could someday result in new therapeutic choices.

Citation: Canario A (2023) An update on recent amyotrophic lateral sclerosis developments Prognostic categories for amyotrophic lateral sclerosis. J Clin Exp Neuroimmunol, 8: 174.

Copyright: © 2023 Canario A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top